Unusual response with tyrosine kinase inhibitor in small-cell lung cancer
The discovery of targetable mutations in non-small-cell lung cancer (NSCLC) has opened up a plethora of therapeutic options. Epidermal growth factor receptor (EGFR) mutations are found in 10%–20% of NSCLC; however, it is extremely rare in small-cell lung cancer (SCLC), and the efficacy of EGFR tyros...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2024-08-01
|
| Colecção: | Annals of Oncology Research and Therapy |
| Assuntos: | |
| Acesso em linha: | https://journals.lww.com/10.4103/aort.aort_15_24 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|